Literature DB >> 11937733

In situ localization of CD83-positive dendritic cells in psoriatic lesions.

Tetsuya Koga1, Hong Duan, Kazunori Urabe, Masutaka Furue.   

Abstract

BACKGROUND: Dendritic cells (DC) are considered to be the most potent antigen-presenting cells, and CD83 is expressed at a high level on immune-competent, activated and mature DC. Although changes in the number or localization of mature and activated CD83+ DC could be expected in psoriasis, there is little information on such changes. AIM: Morphological identification of CD83+ DC in psoriatic skin lesions.
MATERIALS AND METHODS: Immunohistochemical staining was performed in 5 specimens of psoriasis vulgaris and 6 specimens of pustular psoriasis. Formalin-fixed, paraffin-embedded sections were used for examination in this study. The skin sections were pretreated with 0.1% trypsin for 60 min at 37 degrees C prior to immunostaining for CD83.
RESULTS: A small but significant subpopulation of CD83+ DC was found in the upper dermis. In addition, CD83+ DC were occasionally scattered in the epidermis. The most common distribution pattern of CD83+ DC was as clusters with mononuclear lymphoid cells in the upper dermis. CD83+ DC were in close contact with lymphocytes. High-intensity staining of CD83 antigens was detected not only on the surface, but also in the cytoplasm of DC.
CONCLUSION: These results indicate that activated and mature CD83+ DC may play a role in the immune response in psoriasis and provide in vivo support for the concept that CD83+ DC provide signals for direct intralesional T cell activation. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11937733     DOI: 10.1159/000051825

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  8 in total

Review 1.  Immunopathogenesis of psoriasis.

Authors:  Brian J Nickoloff; Jian-Zhong Qin; Frank O Nestle
Journal:  Clin Rev Allergy Immunol       Date:  2007-10       Impact factor: 8.667

2.  Genetic association of apolipoprotein E polymorphisms with inflammatory bowel disease.

Authors:  Ebtissam Saleh Al-Meghaiseeb; Mulfi Mubarak Al-Otaibi; Abdulrahman Al-Robayan; Reem Al-Amro; Ahmd Saad Al-Malki; Misbahul Arfin; Abdulrahman K Al-Asmari
Journal:  World J Gastroenterol       Date:  2015-01-21       Impact factor: 5.742

3.  Pathogenic role for skin macrophages in a mouse model of keratinocyte-induced psoriasis-like skin inflammation.

Authors:  Athanasios Stratis; Manolis Pasparakis; Rudolf A Rupec; Doreen Markur; Karin Hartmann; Karin Scharffetter-Kochanek; Thorsten Peters; Nico van Rooijen; Thomas Krieg; Ingo Haase
Journal:  J Clin Invest       Date:  2006-08       Impact factor: 14.808

Review 4.  Psoriasis pathophysiology: current concepts of pathogenesis.

Authors:  J G Krueger; A Bowcock
Journal:  Ann Rheum Dis       Date:  2005-03       Impact factor: 19.103

5.  Up-regulation of C5a receptor expression and function on human monocyte derived dendritic cells by prostaglandin E2.

Authors:  Oliver Weinmann; Ralf Gutzmer; Jörg Zwirner; Miriam Wittmann; Katja Langer; Margarete Lisewski; Susanne Mommert; Alexander Kapp; Thomas Werfel
Journal:  Immunology       Date:  2003-12       Impact factor: 7.397

6.  Identification of Cell Markers and Their Expression Patterns in Skin Based on Single-Cell RNA-Sequencing Profiles.

Authors:  Xianchao Zhou; Shijian Ding; Deling Wang; Lei Chen; Kaiyan Feng; Tao Huang; Zhandong Li; Yudong Cai
Journal:  Life (Basel)       Date:  2022-04-07

7.  Apolipoprotein E gene polymorphism and serum lipid profile in Saudi patients with psoriasis.

Authors:  Fahad Al Harthi; Ghaleb Bin Huraib; Abdulrahman Zouman; Misbahul Arfin; Mohammad Tariq; Abdulrahaman Al-Asmari
Journal:  Dis Markers       Date:  2014-03-23       Impact factor: 3.434

8.  Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris.

Authors:  Edmund Lee; William L Trepicchio; Judith L Oestreicher; Debra Pittman; Frank Wang; Francesca Chamian; Madhav Dhodapkar; James G Krueger
Journal:  J Exp Med       Date:  2004-01-05       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.